Duke Street Bio
- Location
- London, United Kingdom
- Status
- Active
- Funding
- $4.14M · Equity · Jun 2026
What they do:
Cambridge-based Undecimal Bio, a spin-out from Eleven Therapeutics advancing targeted delivery of siRNA therapeutics, today announced a €16 million ($18 million) Seed financing round to expand DELiveri, its…
Quick facts:
HQ: United Kingdom
Funding:
€16M · Seed · Oct 2026

What they do:
Cori Clinical, a London-based startup that acts as the intelligence layer to accelerate clinical trials, has closed a €3.8 million Seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures,…
Quick facts:
HQ: London, United Kingdom
Funding:
€3.8M · Seed · Oct 2026

What they do:
Unlocking the next generation of mRNA medicines
Quick facts:
HQ: Oxford, United Kingdom

What they do:
RNA medicines for liver diseases
Quick facts:
HQ: London, United Kingdom

What they do:
Robotic human cell manufacturing
Quick facts:
HQ: London, United Kingdom

What they do:
Delivering RNA therapies.
Quick facts:
HQ: London, United Kingdom
London, United Kingdom
Latest round: $4.14M Equity (Jun 2026).
Similar startups: Undecimal Bio, Cori Clinical, and Sensible Biotechnologies.